Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

News feed

Shareholders of GAZ-Tek approved dividends

16:35 GAZT

Shareholders of Gazkon approved dividends

16:33 GAZC

Shareholders of Gaz-service approved dividends

16:31 GAZS

Lukoil pulled out of the Gasha project

16:28 LKOH

Yandex has introduced the YaC 2025 AI Edition

14:00 YDEX

Binnopharm Group creates logistics hub in China

12:42 AFKS

Yandex will launch delivery by robot couriers in all million-plus cities

12:33 YDEX

Kicksharing Yandex Go will reach 45 new cities with the help of a partner

11:23 YDEX

Turnover of the marketplace M.Video in November increased by 61.5%

11:04 MVID

Etalon sells the Silver Fountain business district

08:16 ETLN